vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $142.0M, roughly 1.0× Oncology Institute, Inc.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs -5.3%, a 29.5% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 2.9%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-126.4M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 8.3%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CNS vs TOI — Head-to-Head

Bigger by revenue
CNS
CNS
1.0× larger
CNS
$143.8M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+38.7% gap
TOI
41.6%
2.9%
CNS
Higher net margin
CNS
CNS
29.5% more per $
CNS
24.3%
-5.3%
TOI
More free cash flow
TOI
TOI
$128.6M more FCF
TOI
$2.2M
$-126.4M
CNS
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
8.3%
CNS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
TOI
TOI
Revenue
$143.8M
$142.0M
Net Profit
$34.9M
$-7.5M
Gross Margin
Operating Margin
28.0%
-4.9%
Net Margin
24.3%
-5.3%
Revenue YoY
2.9%
41.6%
Net Profit YoY
-23.9%
43.0%
EPS (diluted)
$0.67
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
TOI
TOI
Q4 25
$143.8M
$142.0M
Q3 25
$141.7M
$136.6M
Q2 25
$136.1M
$119.8M
Q1 25
$134.5M
$104.4M
Q4 24
$139.8M
$100.3M
Q3 24
$133.2M
$99.9M
Q2 24
$121.7M
$98.6M
Q1 24
$122.7M
$94.7M
Net Profit
CNS
CNS
TOI
TOI
Q4 25
$34.9M
$-7.5M
Q3 25
$41.7M
$-16.5M
Q2 25
$36.8M
$-17.0M
Q1 25
$39.8M
$-19.6M
Q4 24
$45.8M
$-13.2M
Q3 24
$39.7M
$-16.1M
Q2 24
$31.8M
$-15.5M
Q1 24
$34.0M
$-19.9M
Operating Margin
CNS
CNS
TOI
TOI
Q4 25
28.0%
-4.9%
Q3 25
34.5%
-5.9%
Q2 25
31.8%
-9.4%
Q1 25
33.6%
-9.5%
Q4 24
35.3%
-11.9%
Q3 24
33.7%
-13.9%
Q2 24
31.5%
-16.6%
Q1 24
32.8%
-19.0%
Net Margin
CNS
CNS
TOI
TOI
Q4 25
24.3%
-5.3%
Q3 25
29.4%
-12.1%
Q2 25
27.1%
-14.2%
Q1 25
29.6%
-18.8%
Q4 24
32.8%
-13.1%
Q3 24
29.8%
-16.1%
Q2 24
26.1%
-15.7%
Q1 24
27.7%
-21.0%
EPS (diluted)
CNS
CNS
TOI
TOI
Q4 25
$0.67
$-0.04
Q3 25
$0.81
$-0.14
Q2 25
$0.72
$-0.15
Q1 25
$0.77
$-0.21
Q4 24
$0.89
$-0.14
Q3 24
$0.77
$-0.18
Q2 24
$0.63
$-0.17
Q1 24
$0.68
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$145.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
$-15.7M
Total Assets
$876.7M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
TOI
TOI
Q4 25
$145.5M
Q3 25
$98.1M
Q2 25
$95.4M
Q1 25
$65.2M
Q4 24
$183.0M
Q3 24
$106.5M
Q2 24
$122.0M
$9.9M
Q1 24
$99.5M
$29.8M
Stockholders' Equity
CNS
CNS
TOI
TOI
Q4 25
$562.0M
$-15.7M
Q3 25
$550.3M
$-12.3M
Q2 25
$528.5M
$-9.0M
Q1 25
$507.7M
$5.1M
Q4 24
$511.7M
$3.6M
Q3 24
$491.0M
$15.5M
Q2 24
$463.2M
$29.2M
Q1 24
$378.9M
$41.3M
Total Assets
CNS
CNS
TOI
TOI
Q4 25
$876.7M
$164.7M
Q3 25
$801.6M
$163.6M
Q2 25
$751.0M
$159.8M
Q1 25
$834.9M
$164.0M
Q4 24
$812.4M
$172.7M
Q3 24
$727.8M
$179.2M
Q2 24
$784.1M
$179.6M
Q1 24
$680.7M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
TOI
TOI
Operating Cash FlowLast quarter
$-120.4M
$3.2M
Free Cash FlowOCF − Capex
$-126.4M
$2.2M
FCF MarginFCF / Revenue
-87.9%
1.5%
Capex IntensityCapex / Revenue
4.2%
0.7%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
TOI
TOI
Q4 25
$-120.4M
$3.2M
Q3 25
$55.1M
$-12.6M
Q2 25
$-67.6M
$-10.2M
Q1 25
$-108.9M
$-5.0M
Q4 24
$96.7M
$4.2M
Q3 24
$25.6M
$819.0K
Q2 24
$31.4M
$-15.7M
Q1 24
$4.9M
$-15.9M
Free Cash Flow
CNS
CNS
TOI
TOI
Q4 25
$-126.4M
$2.2M
Q3 25
$52.6M
$-13.2M
Q2 25
$-69.8M
$-11.4M
Q1 25
$-110.0M
$-5.3M
Q4 24
$85.0M
$2.4M
Q3 24
$24.2M
$417.0K
Q2 24
$27.1M
$-17.5M
Q1 24
$537.0K
$-16.5M
FCF Margin
CNS
CNS
TOI
TOI
Q4 25
-87.9%
1.5%
Q3 25
37.1%
-9.7%
Q2 25
-51.3%
-9.5%
Q1 25
-81.8%
-5.1%
Q4 24
60.8%
2.4%
Q3 24
18.2%
0.4%
Q2 24
22.3%
-17.7%
Q1 24
0.4%
-17.4%
Capex Intensity
CNS
CNS
TOI
TOI
Q4 25
4.2%
0.7%
Q3 25
1.8%
0.4%
Q2 25
1.6%
1.0%
Q1 25
0.8%
0.3%
Q4 24
8.3%
1.8%
Q3 24
1.1%
0.4%
Q2 24
3.5%
1.9%
Q1 24
3.5%
0.6%
Cash Conversion
CNS
CNS
TOI
TOI
Q4 25
-3.45×
Q3 25
1.32×
Q2 25
-1.84×
Q1 25
-2.74×
Q4 24
2.11×
Q3 24
0.65×
Q2 24
0.99×
Q1 24
0.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons